BLRD Research Career Scientist Award Application

BLRD 研究职业科学家奖申请

• 批准号: 10587736
• 负责人: Bruce A. Citron
• 金额: --
• 依托单位: VA NEW JERSEY HEALTH CARE SYSTEM
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-10-01 至 2027-09-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10587736
• 关键词: ALS patients; Accidents; Affect; Aging; Alzheimer' s Disease; Alzheimer' s disease brain; Alzheimer' s disease patient; Alzheimer' s disease related dementia; Amyotrophic Lateral Sclerosis; Animal Model; Animals; Applications Grants; Area; Astrocytes; Attention; Award; Binding; Biochemical Pathway; Biological Models; Brain; CASP3 gene; Caspase; Cells; Central Nervous System; Cessation of life; Characteristics; Chronic; Clinical; Clinical Research; Clinical Trials; Cognitive; Complex; Conflict (Psychology); DNA-Binding Proteins; Development; Disease; Down-Regulation; Family; Gene Expression; Gene Expression Profile; General Population; Genes; Goals; Gulf War; Health; Healthcare; Healthcare Systems; Human; Human Resources; Incidence; Inflammatory; Injury; Intervention; Investigation; Ketones; Knowledge; Laboratories; Life; Measures; Memory; Microglia; Military Personnel; Modeling; Molecular; Molecular Biology; Molecular Genetics; Motor Neuron Disease; Motor Neurons; NF-kappa B; Nerve Degeneration; Neurodegenerative Disorders; Neuroglia; Neurologic; Neurons; Neurosciences; Paralysed; Pathway interactions; Patients; Peptide Hydrolases; Performance; Persian Gulf; Persian Gulf Syndrome; Pharmacologic Substance; Predisposition; Prevalence; Prevention; Problem behavior; Process; Proteins; Publishing; Quality of life; Regulation; Regulatory Pathway; Research; Rest; Risk; Sampling; Scientist; Services; Signal Transduction; Societies; Spinal Cord; Spinal cord injury; Sports; Testing; Therapeutic; Therapeutic Intervention; Transcriptional Regulation; Transgenic Mice; Translating; Traumatic Brain Injury; Traumatic CNS injury; Traumatic injury; Up-Regulation; Veterans; behavior test; bench to bedside; career; cognitive function; cognitive testing; combat; combat zone; cost; cytokine; effective therapy; experience; experimental study; falls; functional loss; improved; improved outcome; military veteran; neuron loss; neuroprotection; neuropsychiatry; new therapeutic target; novel; operation; therapeutic target; therapeutically effective; therapy development; tissue culture; transcription factor; transgenic model of alzheimer disease; treatment optimization; treatment strategy

Traumatic brain injury and other neurodegenerative disorders, e.g., Alzheimer’s Disease (AD), amyotrophic lateral sclerosis (Lou Gehrig’s disease, ALS), and related conditions, have an especially significant and increasing prevalence in the Veteran population. Gulf War illness has a high incidence among Veterans that served in the 1990-1991 Persian Gulf conflict and neurologic problems are common. It is essential that the underlying mechanisms that contribute to these conditions are understood so that treatments can be developed to improve the outcomes for Veterans and others. I have been studying the molecular genetic aspects of neurons and glia in the brain and spinal cord to determine how we can best modulate regulatory pathways to block and reverse neurodegenerative signaling that results in behavioral problems. In the course of these investigations, we examine human CNS samples obtained from brain banks, animal models, and model neurons in tissue culture. We evaluate gene expression changes and interactions that occur during the course of neurodegeneration in a variety of brain and spinal cord samples and model systems to compare alterations that are specific to the various disorders so that we can characterize factors that can be targeted to obtain neuroprotection and improved functional performance. I have determined key mechanisms responsible for central nervous system neurodegeneration. Areas of current discovery include Alzheimer's disease, important to the aging Veteran and general population, and traumatic brain injury which is becoming increasingly understood in terms of injury exposures in sports and importantly, is unfortunately the signature affliction of recently deployed military forces. In this arena I have, for example, identified therapeutic targets by defining neurodegenerative mechanisms and demonstrating that attacking these targets results in reduced activation of caspase- 3, improved neuroprotective gene expression in the brain, and reduced functional deficits, measured with behavioral and cognitive tests, by treatment after injury. We have found that several genes responsible for the loss of neuronal function are influenced significantly by a handful of inflammatory responsive regulatory factors that control the transcription rates, or gene expression, of the proteins important to neuronal health. For example, we found that inflammatory responsive regulatory transcription factors can be modulated to produce neuroprotective levels of intracellular proteins through selective upregulation and downregulation. By treating models with our intracellular, regulatory modulators, we have not only positively influenced biochemical pathways, we have demonstrated improved memory function in neurodegenerative conditions compared to untreated controls. We are currently extending this research to additional neurological problems that occur more frequently in Veterans and are seeking to advance beneficial therapeutic strategies.

创伤性脑损伤和其他神经退行性疾病，如阿尔茨海默病（AD），